Yes. Innocoll is owned by private equity investor Gurnet Point Capital.
Innocoll is headquartered in Princeton, New Jersey.
Innocoll disclosed revenue of 4M USD for 2016 and 3M USD for 2015.
Innocoll has 105 employees.
Innocoll is a medical products company.
Innocoll was founded in 1985.
210 Carnegie Center, Suite 103,
Princeton, New Jersey
08540
United States,
(609) 244-9975
www.innocoll.com
Innocoll is a global commercial stage specialty pharmaceutical and medical device company with late stage development programs targeting areas of significant unmet medical need. Innocoll utilizes its proprietary collagen-based technology platform to develop biodegradable and fully bioresorbable products and product candidates which can be broken down by the body without the need for surgical removal or topical application. Innocoll’s proprietary processes and technologies also enable it to control the texture, consistency, drug elution dynamics, resorption time and other physical characteristics of the finished product. Innocoll was founded in 1985 and is based in Princeton, New Jersey.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
